Related references
Note: Only part of the references are listed.Lack of therapeutic efficacy of an antibody to α4β7 SIVmac251-infected rhesus macaques
Peter Abbink et al.
SCIENCE (2019)
Evaluation of an antibody to α4β7 in the control of SIVmac239-nef-stop infection
M. Di Mascio et al.
SCIENCE (2019)
Blocling α4β7 integrin binding to SIV does not improve virologic control
Nami Iwamoto et al.
SCIENCE (2019)
Integrin α4β7 expression on peripheral blood CD4+ T cells predicts HIV acquisition and disease progression outcomes
Aida Sivro et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
The Control of HIV after Antiretroviral Medication Pause (CHAMP) study: post-treatment controllers identified from 14 clinical studies
Golnaz Namazi et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
A randomized controlled safety/efficacy trial of therapeutic vaccination in HIV-infected individuals who initiated antiretroviral therapy early in infection
Michael C. Sneller et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Sustained virologic control in SIV+ macaques after antiretroviral and α4β7 antibody therapy (Publication with Expression of Concern. See vol. 365, pg. 991, 2019)
Siddappa N. Byrareddy et al.
SCIENCE (2016)
Gut Epithelial Barrier Dysfunction and Innate Immune Activation Predict Mortality in Treated HIV Infection
Peter W. Hunt et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Targeting α4β7 integrin reduces mucosal transmission of simian immunodeficiency virus and protects gut-associated lymphoid tissue from infection
Siddappa N. Byrareddy et al.
NATURE MEDICINE (2014)
In vitro assessment of the effects of vedolizumab binding on peripheral blood lymphocytes
Timothy Wyant et al.
MABS (2013)
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
Brian G. Feagan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Short-Course Antiretroviral Therapy in Primary HIV Infection
Sarah Fidler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
William J. Sandborn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
HIV reservoirs: pathogenesis and obstacles to viral eradication and cure
Tae-Wook Chun et al.
AIDS (2012)
Vedolizumab for the treatment of active ulcerative colitis: A randomized controlled phase 2 dose-ranging study
Asit Parikh et al.
INFLAMMATORY BOWEL DISEASES (2012)
Blocking of α4β7 Gut-Homing Integrin during Acute Infection Leads to Decreased Plasma and Gastrointestinal Tissue Viral Loads in Simian Immunodeficiency Virus-Infected Rhesus Macaques
Aftab A. Ansari et al.
JOURNAL OF IMMUNOLOGY (2011)
Antiretroviral therapy and management of HIV infection
Paul A. Volberding et al.
LANCET (2010)
Preliminary in vivo efficacy studies of a recombinant rhesus anti-alpha(4)beta(7) monoclonal antibody
L. E. Pereira et al.
CELLULAR IMMUNOLOGY (2009)
The integrin α4β7 forms a complex with cell-surface CD4 and defines a T-cell subset that is highly susceptible to infection by HIV-1
Claudia Cicala et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
HIV-1 envelope protein binds to and signals through integrin α4β7, the gut mucosal homing receptor for peripheral T cells
James Arthos et al.
NATURE IMMUNOLOGY (2008)
CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract
JM Brenchley et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract
S Mehandru et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)